Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia. 2012

Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
Neurodegenerative Brain Diseases Group, VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium. jessie.theuns@molgen.vib-ua.be

BACKGROUND Autosomal dominant dopa-responsive dystonia (AD-DRD) is caused by a biochemical defect primarily resulting from guanosine triphosphate cyclohydrolase 1 gene (GCH1) mutations. Few families have been reported without mutations in GCH1. METHODS Genome-wide linkage analysis and positional cloning to identify the genetic defect in a Belgian AD-DRD family was carried out. CONCLUSIONS In this study, we report on the identification and characterization of a novel 24-kb deletion spanning exon 1 and the 5' regulatory region of GCH1 causing a wide spectrum of motor and nonmotor symptoms in a large Belgian AD-DRD family. This large-scale deletion of regulatory sequences leads to decreased GCH1 activity in all carriers, most probably resulting from allelic loss of transcription. We mapped the breakpoints of this deletion to the nucleotide level, allowing the development of a straightforward polymerase chain reaction assay for fast, efficient detection of this large deletion, which will prove valuable for preimplantation genetic diagnosis.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D004421 Dystonia An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77) Muscle Dystonia,Dystonia, Diurnal,Dystonia, Limb,Dystonia, Paroxysmal,Diurnal Dystonia,Dystonia, Muscle,Limb Dystonia,Paroxysmal Dystonia
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006136 GTP Cyclohydrolase (GTP cyclohydrolase I) or GTP 7,8-8,9-dihydrolase (pyrophosphate-forming) (GTP cyclohydrolase II). An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 (GTP cyclohydrolase I) and EC 3.5.4.25 (GTP cyclohydrolase II). GTP 8-Formylhydrolase,GTP Dihydrolase,GTP Ring-Opening Enzyme,7,8-Dihydroneopterintriphosphate Synthetase,GTP Cyclohydrolase I,GTP Cyclohydrolase II,7,8 Dihydroneopterintriphosphate Synthetase,8-Formylhydrolase, GTP,Cyclohydrolase I, GTP,Cyclohydrolase II, GTP,Cyclohydrolase, GTP,Dihydrolase, GTP,GTP 8 Formylhydrolase,GTP Ring Opening Enzyme,Ring-Opening Enzyme, GTP,Synthetase, 7,8-Dihydroneopterintriphosphate

Related Publications

Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
April 2011, Movement disorders : official journal of the Movement Disorder Society,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
May 2015, Journal of child neurology,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
May 2007, Journal of the neurological sciences,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
July 2011, Anales de pediatria (Barcelona, Spain : 2003),
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
March 2012, Journal of child neurology,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
May 2015, Brain : a journal of neurology,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
November 2006, Archives of neurology,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
April 2000, Annals of neurology,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
September 2000, Brain & development,
Jessie Theuns, and David Crosiers, and Luc Debaene, and Karen Nuytemans, and Bram Meeus, and Kristel Sleegers, and Dirk Goossens, and Ellen Corsmit, and Ellen Elinck, and Karin Peeters, and Maria Mattheijssens, and Barbara Pickut, and Jurgen Del-Favero, and Sebastiaan Engelborghs, and Peter Paul De Deyn, and Patrick Cras, and Christine Van Broeckhoven
June 2015, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!